Inogen | INGN - Interest Expense On Debt


Inogen reported 1.03M in Interest Expense on Debt for its fiscal quarter ending in March of 2025.





Interest Expense On Debt Change Date
Abbott USD 68M 26M Mar/2026
Accuray USD 2.88M 72K Dec/2024
AngioDynamics USD 102K 2K Sep/2025
Artivion USD 5.53M 589K Dec/2025
AtriCure USD 1.37M 42K Dec/2025
Baxter International USD 58M 14M Sep/2025
Becton, Dickinson and Co. USD 153M 2M Dec/2025
Boston Scientific USD 90M 0 Mar/2026
Chart Industries USD 75.3M 1.8M Dec/2025
Cooper Companies USD 22.4M 2M Dec/2025
Dexcom USD 4.2M 500K Dec/2025
Edwards Lifesciences USD 35.9M 2.7M Dec/2025
Globus Medical USD 17K 5.1B Dec/2025
Inogen 1.03M 384K Mar/2025
Insulet USD 9.2M 2.2M Dec/2025
Masimo USD 7.5M 1.3M Dec/2025
Medtronic USD 181M 0 Dec/2025
Orthofix International 4.68M 731K Sep/2025
Philips EUR 109M 31M Dec/2025
ResMed USD 8.79M 14.55M Sep/2025
Steris USD 14.9M 0 Dec/2025
Stryker USD 607M 450M Dec/2025
Tandem Diabetes Care USD 2.07M 872.58M Dec/2025
Teleflex USD 28.15M 3.69M Dec/2025
Zimmer Biomet Holdings USD 68.8M 3.1M Mar/2026